Gender, subclinical organ damage and cardiovascular risk stratification in hypertensive patients

References

• Rayner M, Allender S, Scarborough P. Cardiovascular disease in Europe. Eur J Cardiovasc Prev Rehabil 2009;16(Suppl 2):S43-S7
   PubMedGoogle Scholar
• Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635-701
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006;47:1239-312
   PubMed Web of Science ®Google Scholar
• Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-605
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219
   PubMed Web of Science ®Google Scholar
• Ibañez B, Badimon JJ, Garcia MJ. Diagnosis of atherosclerosis by imaging. Am J Med 2009;122(1 Suppl):S15-S25
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003
   PubMed Web of Science ®Google Scholar
• Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998;97:1876-87
   PubMed Web of Science ®Google Scholar
• Jastrzębski M, Klocek M, Czarnecka D, Kawecka-Jaszcz K. Kwas moczowy u chorych na pierwotne nadciśnienie tętnicze – zależności kliniczne i biochemiczne. Nadciśnienie Tętnicze 2008;12:352-8
   Google Scholar
• Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002;89:12-17
   PubMed Web of Science ®Google Scholar
• Short RA, Johnson RJ, Tuttle KR. Uric acid, microalbuminuria and cardiovascular events in high-risk patients. Am J Nephrol 2005;25:36-44
   PubMedGoogle Scholar
• Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-10
   Google Scholar
• Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum acid risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000;36:1072-8
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Wilson PW, Larson MG, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 2004;94:20-4
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Salvetti M, Rosei CA, Paini A. Gender differences in antihypertensive treatment: myths or legends? High Blood Press Cardiovasc Prev 2016;23:105-13
   PubMed Web of Science ®Google Scholar
• Sehestedt T, Jeppesen J, Hansen TW, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 2010;31:883-91
   PubMed Web of Science ®Google Scholar
• Wild SH, Byrne CD, Smith FB, et al. Low ankle–brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study. Diabetes Care 2006;29:637-42
   PubMed Web of Science ®Google Scholar
• Roman MJ, Naqvi TZ, Gardin JM, et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006;19:943-54
   PubMed Web of Science ®Google Scholar
• Bots ML, Baldassarre D, Simon A, et al. Carotid intima–media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J 2007;28:398-406
   PubMed Web of Science ®Google Scholar
• Dijk JM, van der Graaf Y, Bots M, et al. Carotid intima–media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study. Eur Heart J 2006;27:1971-8
   PubMed Web of Science ®Google Scholar
• Stein JH, Fraizer MC, Aeschlimann SE, et al. Vascular age: integrating carotid intima–media thickness measurements with global coronary risk assessment. Clin Cardiol 2004;27:388-92
   PubMed Web of Science ®Google Scholar
• O’Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002;15:426-44
   PubMed Web of Science ®Google Scholar
• Hofman A, Breteler MM, van Duijn CM, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol 2007;22:819-29
   PubMed Web of Science ®Google Scholar
• Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006;113:1213-25
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010;121:505-11
   PubMed Web of Science ®Google Scholar